Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · IEX Real-Time Price · USD
0.720
-0.021 (-2.89%)
At close: Jul 2, 2024, 4:00 PM
0.724
+0.004 (0.56%)
After-hours: Jul 2, 2024, 7:10 PM EDT
Monopar Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MNPR stock have an average target of 2.00, which predicts an increase of 177.78% from the current stock price of 0.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for MNPR stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2 | Strong Buy | Reiterates | $2 | +177.78% | May 10, 2024 |
| JonesTrading | JonesTrading | Hold → Strong Buy Upgrades $2 | Hold → Strong Buy | Upgrades | $2 | +177.78% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +2,261.11% | Jun 1, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $2 | Strong Buy | Maintains | $6 → $2 | +177.78% | May 15, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 29, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.41
from -0.61
EPS Next Year
-0.32
from -0.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 4.5M | 72.5M |
| Avg | n/a | n/a | n/a | 1.5M | 43.9M |
| Low | n/a | n/a | n/a | n/a | 16.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 4,869.1% |
| Avg | - | - | - | - | 2,909.3% |
| Low | - | - | - | - | 1,044.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.41 | -0.29 | -0.18 | -0.33 | 0.02 |
| Avg | -0.41 | -0.32 | -0.28 | -0.32 | 0.02 |
| Low | -0.40 | -0.34 | -0.37 | -0.30 | 0.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.